HealthInvest Partners AB - LA JOLLA PHARMACEUTICAL CO ownership

Quarter-by-quarter ownership
HealthInvest Partners AB ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$4,035,000
+33.7%
1,265,000
+78.9%
9.30%
+93.5%
Q1 2022$3,019,000
-21.8%
707,000
-14.8%
4.81%
-11.6%
Q4 2021$3,860,000
+258.4%
830,000
+207.4%
5.44%
+237.2%
Q3 2021$1,077,000270,0001.61%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,440,419$110,713,00017.54%
Consonance Capital Management LP 2,079,311$66,912,0006.04%
RTW INVESTMENTS, LP 1,063,170$34,213,0005.71%
Broadfin Capital, LLC 1,029,866$33,141,0005.42%
Perceptive Advisors 3,388,611$109,046,0003.62%
SECTORAL ASSET MANAGEMENT INC 854,301$27,491,0003.44%
Boxer Capital, LLC 267,500$8,608,0001.57%
Ghost Tree Capital, LLC 200,000$6,436,0001.51%
EMORY UNIVERSITY 51,632$1,662,0001.43%
Stanley-Laman Group, Ltd. 168,653$5,427,0001.17%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders